WASHINGTON, D.C. – Last night, the Senate released the text of its continuing resolution to fund the federal government thru mid-December. The text also includes a provision delaying implementation of a proposed Office of Management and Budget (OMB) rule that would change the federal government’s grantmaking framework.
The American Cancer Society Cancer Action Network (ACS CAN) previously submitted a comment letter to OMB strongly opposing the proposed rule that would reshape how billions of dollars in research, education, and public health funding are awarded and comes on the heels of significant disruptions to federal research funding over the past year.
A statement from Lisa Lacasse, president of ACS CAN follows:
“Protecting the integrity of federal cancer research funding is essential to ensuring that lifesaving investments remain guided by science, not politics. We are grateful that this bipartisan provision provides the stability researchers and patients need by allowing the National Institutes of Health and the National Cancer Institute to continue their critical work without unnecessary disruption. Every delay in research is a delay in new treatments and new hope for the millions of Americans impacted by cancer. We urge Congress to retain the Senate language and pass a complete continuing resolution promptly so that progress against cancer is not put on hold.”